Cardinal Health Inc — AI technical analysis, September 2026
NYSE/NASDAQ · Health Care
AI Recommendation
HOLD
Technical score 80/100
Last price: $232.65 · 52W range $145.87 – $258.30
Short answer
Should you buy CAH right now? Stockgaide's AI rates CAH as
HOLD, with a technical score of
80/100 at a last price of $232.65.
The 50-day average is above the 200-day average, and RSI sits at 53.3.
Wall Street's consensus rating is 1.79/5.
Full AI analysis for CAH
Strategic Conclusion
Recommendation: Hold
Why? Cardinal Health is in a solid medium-term uptrend with strong analyst support (1.79 Buy rating), but the current P/E of 31.64 is elevated and the stock sits only ~9% below its 52-week high while MACD momentum has turned slightly negative. The risk/reward is balanced but not compelling for fresh entries at current levels.
Ideal profile: Long-term investor with existing position; not ideal for short-term traders chasing momentum here.
Price range: Add on pullback to $216–$225; upside target $250–$258; stop-loss on a close below $216.
Practical action: Hold current positions and do not chase at $234.89. Wait for a pullback to the $216–$225 zone to add, or for a confirmed breakout above $258.30. Reduce exposure if price closes below $216.
1. Recent Price & Momentum
Current price of $234.89 is well above the 52-week low of $145.87 and about 9% below the 52-week high of $258.30 — so the stock is in the upper part of its range.
It is essentially flat around the SMA50 ($234.18), suggesting a pause after a strong rally rather than a clear breakout.
Short-term scenarios: either a push toward $250–$258 if buying resumes, or a consolidation/pullback toward SMA200 at $216.47 if momentum keeps fading.
2. Valuation (P/E)
P/E TTM of 31.64 is high for a healthcare distributor, implying the market is pricing in meaningful future earnings growth or margin improvement.
The current price already reflects a lot of good news; valuation is not a margin of safety at this level.
Dividend yield of 1.88% is modest and does little to justify the multiple.
3. Technical Analysis
SMA50 ($234.18) is above SMA200 ($216.47), confirming a medium-term uptrend / golden-cross territory.
RSI at 53.3 is neutral — neither overbought nor oversold.
MACD (1.26) is below its signal line (1.94) with a negative histogram (-0.68), indicating short-term bearish momentum.
Technical score is 80/100 (Buy), but the score is driven mainly by the moving-average structure, not by current momentum — the mixed signals justify caution.
4. Analyst Consensus
Mean rating 1.79/5 with 21 Buy, 3 Hold, and 0 Sell — a strong bullish consensus.
This aligns with the long-term trend but diverges from the short-term MACD weakness and elevated valuation.
The analyst optimism is likely already priced in near $234; therefore, the consensus does not argue for aggressive buying at this exact level.
Technical signal details
Rule-based read from price and momentum indicators only — the score behind the AI's recommendation above. Technical score: 80/100 (BUY).
50-day moving average is above the 200-day — medium-term uptrend (golden-cross territory).
MACD is below its signal line — bearish momentum.
RSI at 53.29 — neutral momentum.
Wall Street consensus rating of 1.79 — analysts lean Buy.
Stockgaide's AI currently rates CAH as HOLD, with a technical score of 80 out of 100 at a last price of $232.65. This is educational content, not investment advice.
Is CAH in an uptrend?
CAH's 50-day moving average (234.18) is above its 200-day moving average (216.47), which points to a medium-term uptrend.
What is CAH's RSI today?
CAH has a 14-day RSI of 53.3, which places it in neutral territory (above 70 is overbought, below 30 is oversold).
What do analysts say about CAH?
Wall Street analysts covering CAH have a consensus rating of 1.79 out of 5 (1 = Strong Buy), meaning they lean Buy — 21 Buy · 3 Hold · 0 Sell.
Where is CAH trading in its 52-week range?
CAH last traded at $232.65, against a 52-week range of $145.87 to $258.30 — about 77% of the way up that range.
Get the full AI analysis of CAH
Price targets, fundamentals deep-dive and an AI-written report — free, no signup.